Perception and control of allergic rhinitis in primary care.


Journal

NPJ primary care respiratory medicine
ISSN: 2055-1010
Titre abrégé: NPJ Prim Care Respir Med
Pays: England
ID NLM: 101631999

Informations de publication

Date de publication:
20 08 2020
Historique:
received: 20 05 2020
accepted: 03 07 2020
entrez: 22 8 2020
pubmed: 21 8 2020
medline: 2 9 2021
Statut: epublish

Résumé

Perception of a chronic illness is a driver of patient behaviour that may impact treatment outcomes. The cross-sectional PETRA study was designed to describe the links between disease perception, patient behaviour and treatment outcomes in adults with allergic rhinitis (AR). Overall, 687 French general practitioners (GPs) included 1929 analysable patients (mean age: 39 years; intermittent/persistent symptoms: 46.2/52.3%). Of the patients, 14.1% had also been diagnosed with asthma; 71.7% had uncontrolled AR (ARCT score < 20), and 53.6% had a good perception of their illness (BIPQ score < 5). Factors significantly associated with poor perception of AR were ENT (ear/nose/throat) complications, nasal pruritus, uncontrolled AR and asthma. A strong negative correlation was observed between the BIPQ and ARCT scores: the poorer the patient's perception, the less the AR was controlled. Although no causal relationship could be drawn, GP-driven improvement of AR perception could lead to better control of symptoms.

Identifiants

pubmed: 32820169
doi: 10.1038/s41533-020-00195-8
pii: 10.1038/s41533-020-00195-8
pmc: PMC7441396
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

37

Références

World Health Organization. Integrated chronic disease prevention and control https://www.who.int/chp/about/integrated_cd/en/ (2020).
Broadbent, E., Petrie, K. J., Main, J. & Weinman, J. The brief illness perception questionnaire. J. Psychosom. Res. 60, 631–637 (2006).
doi: 10.1016/j.jpsychores.2005.10.020
Demoly, P. et al. Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK. Eur. Respir. Rev. 18, 105–112 (2009).
doi: 10.1183/09059180.00001209
Price, D., Fletcher, M. & van der Molen, T. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim. Care Resp. Med. 24, 14009 (2014).
doi: 10.1038/npjpcrm.2014.9
ISAAC. International Study of Asthma and Allergies in Childhood (ISAAC), http://isaac.auckland.ac.nz/resources/resources.php?menu=res (2020).
Klossek, J. M., Annesi-Maesano, I., Pribil, C. & Didier, A. [INSTANT: national survey of allergic rhinitis in a French adult population based-sample]. Presse Med. 38, 1220–1229 (2009).
doi: 10.1016/j.lpm.2009.05.012
Demoly, P. et al. Assessment of disease control in allergic rhinitis. Clin. Transl. Allergy 3, 7 (2013).
doi: 10.1186/2045-7022-3-7
Bousquet, J. et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63(Suppl 86), 8–160 (2008).
doi: 10.1111/j.1398-9995.2007.01620.x
Didier, A. [Characteristics and assessment of allergic rhinitis symptoms: results of the CESAR survey]. Rev. Fr. Allergol. 49, S65–S68 (2009).
doi: 10.1016/S1877-0320(09)73413-X
Williams, A. & Scadding, G. Is reliance on self-medication and pharmacy care adequate for rhinitis patients? Int. J. Clin. Pr. 63, 98–104 (2009).
doi: 10.1111/j.1742-1241.2008.01944.x
Truong van ut, C. et al. [Knowledge and behavior of patients with allergic rhinitis during a consultation with primary care in general practitioner]. Rev. Fr. Allergol. 52, 429–436 (2012).
doi: 10.1016/j.reval.2012.01.034
Demoly, P. et al. [The offer of care in Allergology in 2011]. Rev. Fr. Allergol. 51, 64–72 (2011).
doi: 10.1016/j.reval.2011.01.008
Cardell, L. O. et al. TOTALL: high cost of allergic rhinitis—a national Swedish population-based questionnaire study. NPJ Prim. Care Resp. Med. 26, 15082 (2016).
doi: 10.1038/npjpcrm.2015.82
Demoly, P., Jankowski, R., Chassany, O., Bessah, Y. & Allaert, F. A. Validation of a self-questionnaire for assessing the control of allergic rhinitis. Clin. Exp. Allergy 41, 860–868 (2011).
doi: 10.1111/j.1365-2222.2011.03734.x
Broadbent, E. et al. A systematic review and meta-analysis of the Brief Illness Perception Questionnaire. Psychol. Health 30, 1361–1385 (2015).
doi: 10.1080/08870446.2015.1070851
Demoly, P., Bosse, I., Fontaine, J. F., Bonniaud, P. & Just, J. [Allergology: the contribution of care pathways]. Rev. Fr. Allergol. 58, 373–382 (2018).
doi: 10.1016/j.reval.2018.04.007
Demoly, P. et al. Development of algorithms for the diagnosis and management of acute allergy in primary practice. World Allergy Organ. J. 12, 100022 (2019).
doi: 10.1016/j.waojou.2019.100022
Migueres, M. et al. Characteristics of patients with respiratory allergy in France and factors influencing immunotherapy prescription: a prospective observational study (Realis). Int. J. Immunopathol. Pharmacol. 24, 387–400 (2011).
doi: 10.1177/039463201102400212
Brozek, J. L. et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision. J. Allergy Clin. Immunol. 126, 466–476 (2010).
doi: 10.1016/j.jaci.2010.06.047
Taytard, A. Rhinite allergique http://www.respir.com/doc/abonne/base/RhiniteAllergique.asp (2005).
Casagrande, J. T., Pike, M. C. & Smith, C. An improved approximate formula for calculating sample sizes for comparing two binomial distributions. Biometrics 34, 483–486 (1978).
doi: 10.2307/2530613

Auteurs

Pascal Demoly (P)

Division of Allergy, Department of Pulmonology, Hôpital Arnaud de Villeneuve, University Hospital of Montpellier, Montpellier, France. pascal.demoly@inserm.fr.
Sorbonne Université, UMR-S 1136 INSERM, IPLESP, EPAR Team, Paris, France. pascal.demoly@inserm.fr.

Isabelle Bossé (I)

Allergology Office, La Rochelle, France.

Pascal Maigret (P)

Menarini France, Rungis, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH